Solid-Phase Peptide Synthesis: How a Sequence Is Built

Almost every synthetic research peptide is made by solid-phase peptide synthesis, a method that builds the chain one residue at a time on an insoluble support. Understanding the cycle explains most of what later appears on a chromatogram.

The idea

The peptide is assembled while anchored to a resin bead. Because the growing chain is attached to something insoluble, excess reagents and by-products can be washed away simply by filtering and rinsing, without isolating an intermediate at any step. That is the innovation: purification between steps becomes a rinse rather than a separation.

Synthesis runs from the C-terminus toward the N-terminus, which is the opposite direction to biological translation. The first residue is attached to the resin, and each subsequent residue is added to the free amino group of the one before it.

The cycle

Each residue is added by repeating four operations. In Fmoc chemistry, the most common approach for research material:

• Deprotection. The Fmoc group shielding the N-terminal amine of the growing chain is removed with a base, usually piperidine, exposing the amine for the next coupling.
• Washing. Reagents and cleaved protecting groups are rinsed away.
• Coupling. The next amino acid, itself Fmoc-protected and with its side chain protected, is activated and forms an amide bond with the exposed amine.
• Washing again. Excess activated amino acid is removed before the next deprotection.

The cycle repeats once per residue. A twenty-nine residue peptide such as GHRH(1-29) requires twenty-nine of them. Sermorelin as the reference GHRH analog covers that sequence.

Why yield compounds with length

No coupling step is perfectly efficient. If each achieves 99%, then after ten residues the proportion of chains carrying the full intended sequence is roughly 90%; after thirty it is around 74%. The arithmetic is unforgiving and it is the central reason longer peptides are harder and more expensive to make well.

The chains that fail a coupling do not disappear. They continue through subsequent cycles missing a residue, which is the origin of deletion sequences — the impurity class that most closely resembles the target and is therefore hardest to separate from it. Deletion, truncation and oxidation impurities covers what each looks like.

Capping, and why it helps

Many protocols add a capping step after each coupling: any chain that failed to react is acetylated, permanently blocking its N-terminus. Those chains stop growing rather than continuing as deletion sequences.

The benefit is not a higher yield of target — capped chains are lost either way — but a cleaner separation afterwards. A short, capped fragment differs substantially from the full-length target in hydrophobicity and is straightforward to remove chromatographically. A deletion sequence differing by one residue is not.

Cleavage and what comes off the resin

When the sequence is complete, a strong acid — typically trifluoroacetic acid with scavengers — cleaves the peptide from the resin and removes the side-chain protecting groups simultaneously. The scavengers are there to intercept the reactive species released during that step, which would otherwise modify sensitive residues.

The crude product is then purified, usually by preparative reversed-phase HPLC, and lyophilised. The acid used at cleavage and in the purification mobile phase is why so much synthetic peptide is isolated as a trifluoroacetate salt. TFA and acetate counter-ions covers what that means for the mass in the vial, and lyophilisation covers the final drying step.

All material is supplied for laboratory research use only. It is not a drug, not a supplement, and not for use in humans or animals.